plecanatide: Clinical Trials

6 trials of plecanatide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Active not recruiting 1
Phase 31Completed 1

Follow plecanatide: new trials by email Literature Review of plecanatide trials Research Report on plecanatide

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC
plecanatide, Placebo - Functional Constipation (FC)
Phase 2Active not recruitingBausch Health Americas, Inc.1802026-08-182026-10-29
Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)
Plecanatide, Matching placebo - Irritable Bowel Syndrome With Constipation
Phase 2CompletedBausch Health Americas, Inc.2182018-06-302025-12-31
An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation
Plecanatide, Matching placebo - Chronic Idiopathic Constipation
Phase 2CompletedBausch Health Americas, Inc.1242017-01-012019-10-04
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Plecanatide, Placebo - Irritable Bowel Syndrome Characterized by Constipation
Phase 2CompletedBausch Health Americas, Inc.4282012-11-012019-05-28
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
plecanatide, Placebo - Chronic Idiopathic Constipation
Phase 2 / Phase 3CompletedBausch Health Americas, Inc.9512011-10-012019-05-28
SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation
SP-304 0.3 mg, SP-304 1.0 mg, SP-304 3.0 mg - Chronic Idiopathic Constipation
Phase 2CompletedBausch Health Americas, Inc.842010-03-012020-01-02

Conditions studied

Constipation (3)  ·  Irritable Bowel Syndrome (1)

Sponsors

Bausch Health Americas, Inc. (6)

Countries

United States (6)

Top investigators

Gary S Jacob, Ph.D. (1)  ·  Philip B Miner, MD (1)